Liquid biopsy (LB) is a non-invasive approach representing a promising tool for new
precision medicine strategies for cancer treatment. However, a comprehensive analysis of …

The origin of metastases is a topic that has sparked controversy. Despite recent
advancements, metastatic disease continues to pose challenges. The first admitted model of …

Circulating tumor DNA (ctDNA) is one conventional type of liquid biopsy that can be
collected to dynamically monitor disease status. However, its potential clinical value and …

Background With more than 15,000 new cases/year in France and 2,000 deaths, cutaneous
melanoma represents approximately 4% of incidental cancers and 1.2% of cancer related …

Simple Summary Endocrine therapy (ET) remains the mainstay of treatment for Hormone
Receptor-positive breast cancer, both in the early and advanced settings. The acquisition of …

Breast cancer is clinically and biologically heterogeneous and is classified into different
subtypes according to the molecular landscape of the tumor. Triple-negative breast cancer is …

Simple Summary There is no valid consensus regarding follow-up for pancreatic cancer in
terms of recommended investigations in routine practice. By analogy with other pathologies …

Many people die from lung and breast cancer. Consequently, both physicians and
researchers strive to provide reliable monitoring for disease, diagnosis and prognosis as …

Background/aim: A comprehensive liquid biopsy panel was performed on 242 patients to
explain the challenges, limitations, and methods in liquid biopsy testing. Material and …

Breast cancer is clinically and biologically heterogeneous and is classified into different
subtypes according to the molecular landscape of the tumor. Triple-negative breast cancer is …